As clinical research professionals, taking care of people is at the heart of everything we do. Our global clinical research community is facing an unprecedented situation and the health and safety of our community, including our staff, clients, and partners, are our top priority at Avania.
While COVID-19 continues to impact communities around the globe, our operations are running strong. Our business continuity plan and investment in technology allow us to offer uninterrupted access and high-quality service to address your every CRO need during this difficult time.
We are committed to limiting the spread of this virus and safeguarding the health of our stakeholders by:
Listening to the Experts: The Avania leadership team is closely monitoring new developments and following the guidance from the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and the European Centre for Disease Prevention and Control (ECDC), along with local governments and authorities in all countries in which we operate.
Supporting You: We have implemented a work from home policy which not only allows our staff to take precautionary measures to protect their well-being and limit the potential to spread the virus, but also enables us to ensure there will be no interruption to our service level agreements, globally. Please expect uninterrupted access to our operational experts and know that we remain committed to meeting your CRO needs with the highest quality.
Continuing to Foster Connections: We recognize human connection is essential to our research community and while many industry events have been canceled or postponed — and in light of travel restrictions due to COVID-19 which limit our opportunity to connect in person — our team will remain available and looks forward to staying in touch virtually to help foster this important connection. Virtual does not have to mean impersonal.
We are grateful for your support. Stay well.